Abstract
Lithium hydroxybutyrate has a broad spectrum of action and exhibits its activity in widely different pathological states [2]. The writers showed previously [I] that this compound, if given prophylactically, inhibits the development of peritonitis in rats caused by intraperitoneal injection of silver nitrate, and edema of the limbs caused by subplantar injection of biologically active substances which are mediators of inflammation. One of the most important criteria for evaluation of the compound as an anti-inflammatory agent is its ability to inhibit the development of carrageenin inflammation [8].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
